Skip to Main Content

Author Details

Rekha Garg
University of Florida
1991
39
18
PMIDPaper TitleJournal TitlePublished Year
37190274Association of Suppressive Myeloid Cell Enrichment with Aggressive Oropharynx Squamous Cell Carcinoma.Cancers (Basel)2023
35427184Feasibility and Prediction of Adverse Events in a Postoperative Monitoring Program of Patient-Reported Outcomes and a Wearable Device Among Gynecologic Oncology Patients.JCO Clin Cancer Inform2022
35834946Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1).Neoplasia2022
23814522Assessment of risk evaluation and mitigation strategies in oncology: summary of the oncology risk evaluation and mitigation strategies workshop.J Oncol Pract2013
20947724NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders.J Natl Compr Canc Netw2010
16684364Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis.Crit Care2006
16280057Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis.Crit Care2005
16192478Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.N Engl J Med2005
16290973Racial differences in outcome and treatment effect in congestive heart failure.Am Heart J2005
15640631The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis.Crit Care Med2004
16295369Pneumocystis carinii pneumonia after renal transplantation.Indian J Pathol Microbiol2004
15640632Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial.Crit Care Med2004
12612867The effect of digoxin on the quality of life in patients with heart failure.J Card Fail2003
14643078Lessons learned from the DIG trial.Control Clin Trials2003
14643077The role of the data coordinating center in the IRB review and approval process: the DIG trial experience.Control Clin Trials2003
14643076The use of regional coordinating centers in large clinical trials: the DIG trial.Control Clin Trials2003
14643075The role of the pharmacy coordinating center in the DIG trial.Control Clin Trials2003
14643073Overview of the DIG trial.Control Clin Trials2003
14643074The role of the data coordinating center in the DIG trial.Control Clin Trials2003
12008182Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure.Am J Cardiol2002
11054628Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease.Am Heart J2000
11011338Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).Am Heart J2000
10979113Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial.JAMA2000
10577438Niacin treatment increases plasma homocyst(e)ine levels.Am Heart J1999
10362347Cardiac glycosides in the next millennium.Prog Cardiovasc Dis1999
10073863Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study.Am J Cardiol1999
10501408Compliance to multiple interventions in a high risk population.Ann Epidemiol1999
9508228The relationship between cardiothoracic ratio and left ventricular ejection fraction in congestive heart failure. Digitalis Investigation Group.Arch Intern Med1998
9605778Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.Arch Intern Med1998
8970426Etiology and characteristics of congestive heart failure in blacks.Am J Cardiol1996
7654275Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.JAMA1995
7514238Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials.J Cardiovasc Pharmacol1993
8494473Alcohol consumption and risk of ischemic heart disease in women.Arch Intern Med1993
8376694Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine.J Am Coll Cardiol1993
8104204Current and ongoing randomized trials in heart failure and left ventricular dysfunction.J Am Coll Cardiol1993
1626493Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure.Am J Cardiol1992
1573431Regional variation in ischemic heart disease incidence.J Clin Epidemiol1992
1723188Analyses by the intention-to-treat principle in randomized trials and databases.Pacing Clin Electrophysiol1991
2019186Randomized trials to assess the long-term effects of therapies on angiographic end points.Chest1991
  • 1 - 39 of 39

Recommended Authors

Husam M Salah
University of Arkansas for Medical Sciences
Career Start Year 2015
Number of shared co-authors 0
Sripal Bangalore
New York University Grossman School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Jos?? M Castellano
Hospital Universitario HM Monteprincipe, Grupo HM Hospitales
Career Start Year 2003
Number of shared co-authors 0
Kevin J Anstrom
University of North Carolina at Chapel Hill
Career Start Year 1999
Number of shared co-authors 1
Stephen E Kimmel
University of Florida
Career Start Year 1995
Number of shared co-authors 0
Gerasimos Filippatos
National and Kapodistrian University of Athens, Attikon University Hospital
Career Start Year 1993
Number of shared co-authors 0
Ali Serdar Fak
Marmara University, Hypertension and Atherosclerosis Research Center
Career Start Year 1992
Number of shared co-authors 0
Peter A McCullough
Truth for Health Foundation
Career Start Year 1992
Number of shared co-authors 1
R. Scott Wright
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 0
Jean-Claude Tardif
Montreal Heart Institute, Universite de Montreal
Career Start Year 1991
Number of shared co-authors 1
Yves Rosenberg
National Heart Lung and Blood Institute
Career Start Year 1991
Number of shared co-authors 2
Elizabeth O Ofili
Morehouse School of Medicine
Career Start Year 1990
Number of shared co-authors 1
Chul Ahn
University of Texas Southwestern Medical Center
Career Start Year 1989
Number of shared co-authors 0
Deepak L Bhatt
Icahn School of Medicine at Mount Sinai Health System
Career Start Year 1988
Number of shared co-authors 0
Stuart D Katz
NYU Grossman School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Mark A Munger
Department of Pharmacotherapy, University of Utah Health
Career Start Year 1986
Number of shared co-authors 0
Jalal K Ghali
Department of Medicine Morehouse School of Medicine Atlanta GE.
Career Start Year 1985
Number of shared co-authors 1
John G F Cleland
British Heart Foundation Centre of Research Excellence, University of Glasgow
Career Start Year 1983
Number of shared co-authors 1
Kent R Bailey
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 0
George Sopko
and Blood Institute
Career Start Year 1982
Number of shared co-authors 1
David J Maron
Stanford University School of Medicine
Career Start Year 1981
Number of shared co-authors 0
JoAnn Lindenfeld
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 0
Ileana L Pi??a
Thomas Jefferson University
Career Start Year 1980
Number of shared co-authors 0
William S Weintraub
MedStar Health Research Institute and Georgetown University
Career Start Year 1979
Number of shared co-authors 0
Robert M Califf
From the National Institutes of Health
Career Start Year 1978
Number of shared co-authors 2
Philip T Sager
Inc., Canada Cardiovascular Research Institute, Stanford University
Career Start Year 1975
Number of shared co-authors 0
Philip Greenland
Feinberg School of Medicine, Northwestern University
Career Start Year 1972
Number of shared co-authors 1
Kenneth Dickstein
University of Bergen
Career Start Year 1971
Number of shared co-authors 0
Alan S Go
Kaiser Permanente Northern California
Career Start Year 1962
Number of shared co-authors 0
Kurt Boman
Research Unit, Skelleftea County Hospital
Career Start Year 1949
Number of shared co-authors 0

Collaborators

Salim Yusuf
Co-authored papers 12
Pierre-Fran??ois Laterre
Centre Hospitalier Regional Mons-Hainaut
Co-authored papers 3
Howard Levy
Howard Levy Consulting LLC
Co-authored papers 2
David R Nelson
Clinical and Translational Science Institute, University of Florida
Co-authored papers 2
Derek C Angus
University of Pittsburgh Medical Center
Co-authored papers 2
Daniel E Ball
Lilly Research Laboratories
Co-authored papers 2
W Craig Johnson
Co-authored papers 2
G Clermont
University of Pittsburgh
Co-authored papers 1
Bruce M Psaty
Co-authored papers 1
Jean-Fran??ois Dhainaut
Universite Paris Descartes
Co-authored papers 1
Milton Packer
Co-authored papers 1
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Susan R Heckbert
Co-authored papers 1
Jennifer A Wargo
Co-authored papers 1
Arthur P Wheeler
Vanderbilt University
Co-authored papers 1
Eugene Wesley Ely
Vanderbilt University Medical Center
Co-authored papers 1
Lisa A Weissfeld
The Clinical Research, University of Pittsburgh
Co-authored papers 1
Gordon R Bernard
Vanderbilt University
Co-authored papers 1
Jean-Louis Vincent
Erasme Hospital, Universite Libre de Bruxelles
Co-authored papers 1
James M Hoffman
St. Jude Children's Research Hospital Memphis
Co-authored papers 1
Nicholas L Smith
University of Washington
Co-authored papers 1
Dennis W Raisch
The University of New Mexico
Co-authored papers 1
Andrew G Sikora
Co-authored papers 1
Release 1.2